# FDA Inspection 1043309 - GlaxoSmithKline, LLC. - January 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/0b5167aa-cc71-4870-ab00-b2a540d138b4
Source feed: FDA_Inspections

> FDA Inspection 1043309 for GlaxoSmithKline, LLC. on January 26, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1043309
- Company Name: GlaxoSmithKline, LLC.
- Inspection Date: 2018-01-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1274978 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/b8f525fd-c7f3-4be7-96cb-3b6521628f55)
- [FDA Inspection 1261906 - 2024-09-25](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/a2084345-5a0c-4a87-8363-0d2bd8669d45)
- [FDA Inspection 1211050 - 2023-06-20](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/8485f852-2d88-42c0-9721-aadfe170918e)
- [FDA Inspection 927643 - 2015-05-08](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/fbc0c9fa-7686-48d1-9dc5-f3490f633878)
- [FDA Inspection 730716 - 2011-06-07](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/3c7723f0-8902-4683-af32-1698224dcb83)

Company: https://www.keypedia.com/companies/glaxosmithkline-llc/7ab59069-93ea-4898-a74a-874992c27286

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c